Glipark PM 2mg/500mg/15mg Tablet SR
Marketer
Park Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glipark PM 2mg/500mg/15mg Tablet SR
Combiflor PM 2mg/500mg/15mg Extended-Release Tablets regulate blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It promotes efficient insulin use, thus reducing blood sugar. Dosage and frequency for Combiflor PM should strictly follow your physician's instructions. Administer with food to prevent gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular regimen. Never double the dose. Overdosing can cause hypoglycemia. Concurrent use with other antidiabetic agents, alcohol, or skipped meals may trigger hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac issues to your doctor. Pregnant or lactating individuals require medical consultation before use. Baseline kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it can heighten the risk of side effects.
Primary Ingredients of Glipark PM 2mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glipark PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glipark PM 2mg/500mg/15mg Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; do not crush, chew, or divide it. Consume Glipark PM 2mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of Glipark PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glipark PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; refrain from chewing, crushing, or fracturing it. The Glipark PM 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Glipark PM 2mg/500mg/15mg Tablet SR works:
Glipark PM 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glipark PM 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Glipark PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glipark PM 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Glipark PM 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glipark PM 2mg/500mg/15mg SR tablets. Physician consultation is recommended. Regular assessment of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glipark PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Glipark PM 2mg/500mg/15mg SR tablets are unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Glipark PM 2mg/500mg/15mg Tablet SR :
Should you forget to take a Glipark PM 2mg/500mg/15mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glipark PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently